MedicarePartD.guide

A non-government resource built from CMS public data

Maintenance inhalers for COPD and asthma on AARP Medicare Rx Saver from UHC (S5921-373)

Trelegy, Breztri, Symbicort, Spiriva and the other everyday inhalers, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Nevada
Premium
$76.70/month
Deductible
$615.00
Change plan

8 of 13 COPD and asthma inhalers are covered on this plan. None require prior authorization.

5 aren't on the formulary, including Breztri Aerosphere and Incruse Ellipta.

  • Trelegy Ellipta
    fluticasone/umeclidinium/vilanterol
    Covered
    from $136.31
    Tier 3
  • Anoro Ellipta
    umeclidinium/vilanterol
    Covered
    $98.45
    Tier 3
  • Stiolto Respimat
    tiotropium/olodaterol
    Covered
    $94.76
    Tier 3
  • Spiriva
    tiotropium
    Covered
    from $71.34
    Tier 3
  • Breo Ellipta
    fluticasone/vilanterol
    Covered
    from $79.18
    Tier 3
  • Symbicort
    budesonide/formoterol
    Covered
    from $39.33
    Tier 3
  • Wixela Inhub
    fluticasone/salmeterol, generic Advair
    Covered
    from $17.01
    Tier 3
  • Dulera
    mometasone/formoterol
    Covered
    from $119.31
    Tier 4
Not on the formulary
Breztri Aerosphere, Incruse Ellipta, budesonide-formoterol, Advair, Arnuity Ellipta

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list